Clovis Oncology, Inc. Quarterly Operating Income (Loss) in USD from Q1 2011 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Clovis Oncology, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2011 to Q3 2022.
  • Clovis Oncology, Inc. Operating Income (Loss) for the quarter ending September 30, 2022 was -$44.2M, a 23% increase year-over-year.
  • Clovis Oncology, Inc. Operating Income (Loss) for the twelve months ending September 30, 2022 was -$207M, a 13.2% increase year-over-year.
  • Clovis Oncology, Inc. annual Operating Income (Loss) for 2021 was -$226M, a 25.3% increase from 2020.
  • Clovis Oncology, Inc. annual Operating Income (Loss) for 2020 was -$302M, a 19.8% increase from 2019.
  • Clovis Oncology, Inc. annual Operating Income (Loss) for 2019 was -$377M, a 12.9% decline from 2018.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$207M -$44.2M +$13.2M +23% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 -$220M -$59.4M -$1.8M -3.12% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-08
Q1 2022 -$218M -$50.4M +$7.65M +13.2% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 -$226M -$52.7M +$12.3M +18.9% Oct 1, 2021 Dec 31, 2021 10-K 2022-02-24
Q3 2021 -$238M -$57.5M +$15.1M +20.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$253M -$57.6M +$25.1M +30.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$278M -$58M +$24M +29.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$302M -$65M +$26.7M +29.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 -$329M -$72.5M +$33.9M +31.8% Jul 1, 2020 Sep 30, 2020 10-K 2022-02-24
Q2 2020 -$363M -$82.6M +$10.8M +11.6% Apr 1, 2020 Jun 30, 2020 10-K 2022-02-24
Q1 2020 -$374M -$82M +$3.19M +3.74% Jan 1, 2020 Mar 31, 2020 10-K 2022-02-24
Q4 2019 -$377M -$91.7M +$5.31M +5.47% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$382M -$106M -$17.3M -19.4% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-25
Q2 2019 -$365M -$93.5M -$14.4M -18.3% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-25
Q1 2019 -$350M -$85.2M -$16.5M -24.1% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-25
Q4 2018 -$334M -$97M -$33.8M -53.4% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-26
Q3 2018 -$300M -$89.2M -$28.6M -47.3% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-26
Q2 2018 -$271M -$79M -$21.3M -36.8% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-26
Q1 2018 -$250M -$68.7M -$12.5M -22.3% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-26
Q4 2017 -$238M -$63.2M +$3.93M +5.86% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 -$242M -$60.5M +$3.47M +5.43% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-28
Q2 2017 -$245M -$57.7M +$98.9M +63.1% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-28
Q1 2017 -$344M -$56.2M +$28.8M +33.9% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-28
Q4 2016 -$373M -$67.1M +$79.8M +54.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-27
Q3 2016 -$453M -$64M +$33.3M +34.2% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-27
Q2 2016 -$486M -$157M -$88.3M -129% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-27
Q1 2016 -$397M -$85M -$20.7M -32.3% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-27
Q4 2015 -$377M -$147M -$93M -173% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-23
Q3 2015 -$284M -$97.3M -$56.1M -137% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-23
Q2 2015 -$228M -$68.3M -$33.4M -95.4% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-23
Q1 2015 -$194M -$64.2M -$35.7M -125% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-23
Q4 2014 -$158M -$53.9M -$25.4M -89.1% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-29
Q3 2014 -$133M -$41.1M -$20.7M -102% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-29
Q2 2014 -$112M -$35M -$15.7M -81.1% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-29
Q1 2014 -$96.7M -$28.5M -$12.9M -82.7% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-29
Q4 2013 -$83.8M -$28.5M -$7.44M -35.3% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-27
Q3 2013 -$76.3M -$20.4M -$2.16M -11.8% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-27
Q2 2013 -$74.2M -$19.3M -$3.79M -24.4% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-27
Q1 2013 -$70.4M -$15.6M +$3.4M +17.9% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-27
Q4 2012 -$73.8M -$21.1M -$6.58M -45.4% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-28
Q3 2012 -$67.2M -$18.2M -$4.94M -37.2% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-28
Q2 2012 -$62.3M -$15.5M +$2.86M +15.6% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-28
Q1 2012 -$65.1M -$19M -$10.5M -125% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-28
Q4 2011 -$54.6M -$14.5M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-14
Q3 2011 -$13.3M Jul 1, 2011 Sep 30, 2011 10-K 2013-03-14
Q2 2011 -$18.4M Apr 1, 2011 Jun 30, 2011 10-K 2013-03-14
Q1 2011 -$8.45M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.